Philip Lester

577 total citations
13 papers, 469 citations indexed

About

Philip Lester is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Philip Lester has authored 13 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Philip Lester's work include Protein purification and stability (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Philip Lester is often cited by papers focused on Protein purification and stability (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Philip Lester collaborates with scholars based in Germany, United States and Sweden. Philip Lester's co-authors include Stuart E. Builder, Steven J. Shire, Jun Liu, David H. Reifsnyder, Roger A. Hart, John R. Ogez, Josefine Persson, Jürgen Hubbuch, Dana C. Andersen and Robert Fahrner and has published in prestigious journals such as Biochemistry, Endocrinology and Journal of Chromatography A.

In The Last Decade

Philip Lester

13 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Lester Germany	12	294	133	73	73	71	13	469
Suresh Vunnum United States	14	553 1.9×	294 2.2×	58 0.8×	144 2.0×	48 0.7×	19	675
Y. KURODA Japan	9	294 1.0×	32 0.2×	34 0.5×	25 0.3×	17 0.2×	22	519
Huiqiang Li China	10	141 0.5×	26 0.2×	62 0.8×	56 0.8×	32 0.5×	46	338
Andrew A. Kosky United States	8	277 0.9×	141 1.1×	28 0.4×	40 0.5×	11 0.2×	8	338
Christof Regl Austria	12	255 0.9×	77 0.6×	19 0.3×	40 0.5×	16 0.2×	29	361
Zhi Shang China	12	446 1.5×	13 0.1×	33 0.5×	96 1.3×	45 0.6×	22	632
Olga Will Germany	11	138 0.5×	32 0.2×	35 0.5×	44 0.6×	14 0.2×	27	352
T.I. P̌řistoupil Czechia	10	163 0.6×	25 0.2×	11 0.2×	125 1.7×	46 0.6×	59	370
Litao Yang China	13	494 1.7×	12 0.1×	28 0.4×	238 3.3×	77 1.1×	27	717
Michael Z. Wang United States	14	338 1.1×	21 0.2×	37 0.5×	30 0.4×	7 0.1×	21	667

Countries citing papers authored by Philip Lester

Since Specialization

Citations

This map shows the geographic impact of Philip Lester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Lester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Lester more than expected).

Fields of papers citing papers by Philip Lester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Lester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Lester. The network helps show where Philip Lester may publish in the future.

Co-authorship network of co-authors of Philip Lester

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Lester. A scholar is included among the top collaborators of Philip Lester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Lester. Philip Lester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

McDonald, Paul C., et al.. (2015). The rapid identification of elution conditions for therapeutic antibodies from cation-exchange chromatography resins using high-throughput screening. Journal of Chromatography A. 1433. 66–74. 28 indexed citations

Wang, Hua, Philip Lester, Qi Chen, et al.. (2013). Porcine circovirus (PCV) removal by Q sepharose fast flow chromatography. Biotechnology Progress. 29(6). 1464–1471. 12 indexed citations

Zhang, Min, Michael Lee, Lenore A. Norling, et al.. (2013). Quality by design approach for viral clearance by protein a chromatography. Biotechnology and Bioengineering. 111(1). 95–103. 30 indexed citations

Lester, Philip, et al.. (2012). Application of genetic algorithms and response surface analysis for the optimization of batch chromatographic systems. Biochemical Engineering Journal. 63. 66–75. 14 indexed citations

Richter, Carolin, et al.. (2012). High‐throughput methods for miniaturization and automation of monoclonal antibody purification processes. Biotechnology Progress. 28(3). 723–732. 51 indexed citations

Persson, Josefine, Dana C. Andersen, & Philip Lester. (2005). Evaluation of different primary recovery methods for E. coli‐derived recombinant human growth hormone and compatibility with further down‐stream purification. Biotechnology and Bioengineering. 90(4). 442–451. 33 indexed citations

Persson, Josefine & Philip Lester. (2004). Purification of antibody and antibody‐fragment from E. coli homogenate using 6,9‐diamino‐2‐ethoxyacridine lactate as precipitation agent. Biotechnology and Bioengineering. 87(3). 424–434. 10 indexed citations

Dubaquié, Yves, Deborah L. Mortensen, Deborah Hogue, et al.. (2001). Binding Protein-3-Selective Insulin-Like Growth Factor I Variants: Engineering, Biodistributions, and Clearance. Endocrinology. 142(1). 165–173. 15 indexed citations

Fahrner, Robert, Philip Lester, Gregory S. Blank, & David H. Reifsnyder. (1999). Non-flammable preparative reversed-phase liquid chromatography of recombinant human insulin-like growth factor-I. Journal of Chromatography A. 830(1). 127–134. 11 indexed citations

10.

Iyer, Harish, et al.. (1999). Use of the steric mass action model in ion-exchange chromatographic process development. Journal of Chromatography A. 832(1-2). 1–9. 35 indexed citations

11.

Fahrner, Robert, Philip Lester, Gregory S. Blank, & David H. Reifsnyder. (1998). Real-time control of purified product collection during chromatography of recombinant human insulin-like growth factor-I using an on-line assay. Journal of Chromatography A. 827(1). 37–43. 23 indexed citations

12.

Liu, Jun, Philip Lester, Stuart E. Builder, & Steven J. Shire. (1995). Characterization of Complex Formation by Humanized Anti-IgE Monoclonal Antibody and Monoclonal Human IgE. Biochemistry. 34(33). 10474–10482. 122 indexed citations

13.

Hart, Roger A., Philip Lester, David H. Reifsnyder, John R. Ogez, & Stuart E. Builder. (1994). Large Scale, In Situ Isolation of Periplasmic IGF–I from E. coli. Bio/Technology. 12(11). 1113–1117. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact